NCT00004251View on ClinicalTrials.gov

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 19, 2000

Primary Completion Date

September 13, 2002

Study Completion Date

January 18, 2011

Conditions
Endometrial Cancer
Interventions
DRUG

letrozole

2.5 mg of letrozole per day

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK